Parkinson Disease and Complex Parkinsonism

Gene: MAPT

Green List (high evidence)

MAPT (microtubule associated protein tau)
EnsemblGeneIds (GRCh38): ENSG00000186868
EnsemblGeneIds (GRCh37): ENSG00000186868
OMIM: 157140, Gene2Phenotype
MAPT is in 6 panels

2 reviews

Ellen McDonagh (Genomics England Curator)

PMID: 28334843 - new publication providing further evidence. Autophagy-upregulating therapies may be a strategy for the treatment for tauopathies.
Created: 14 Aug 2017, 3:23 p.m.
Comment on list classification: Multiple families/cases reported in OMIM for Dementia, frontotemporal, with parkinsonism for different variants. Also green on the Early onset dementia (encompassing fronto-temporal dementia and prion disease) version 1.2 panel.
Created: 2 Nov 2016, 1:26 p.m.
Comment on list classification: Is on the Dementia NGS Panel in the UCLH National Hospital for Neurology and Neurosurgery & Institute of Neurology (NHNN) Neurogenetics genetic testing manual, and consideration of testing for this gene is suggested in the case of familial or unusual syndromes, which may include earlier age of onset: "Complicated parkinsonism such as MSA and PSP generally do not appear to have a high recurrence risk. However, in the case of familial or unusual syndromes, which may include earlier age of onset, consideration to sequence the MAPT gene is suggested. In MSA approximately 10% of patients have a spinocerebellar ataxia (SCA) expansion."
Created: 10 Jun 2016, 10:45 a.m.

Phenotypes
28334843

Arianna Tucci (Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square)

Green List (high evidence)

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
complex neurodegenerative disorder: mainly frontotemporal dementia, but also progressive supranuclear palsy, corticobasal degeneration, parkinsonism

Publications

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
  • Eligibility statement prior genetic testing
  • UKGTN
  • Radboud University Medical Center, Nijmegen
  • Expert
Phenotypes
  • Dementia, frontotemporal, with or without parkinsonism, 600274
  • {Parkinson disease, susceptibility to}, 168600
  • Pick disease, 172700
  • Supranuclear palsy, progressive, 601104
  • Supranuclear palsy, progressive atypical, 260540
  • Tauopathy and r
  • Pick disease, 172700
  • PARKINSON-DEMENTIA SYNDROME
  • clinical presentation suggestive of cortico-basal/PSP syndrome
Tags
treatable
OMIM
157140
Clinvar variants
Variants in MAPT
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

14 Aug 2017, Gel status: 4

Set publications

Ellen McDonagh (Genomics England Curator)

Publications for MAPT were set to 28334843;20301678

19 Dec 2016, Gel status: 4

panel promoted to version 1

Ellen McDonagh (Genomics England Curator)

19th Dec 2016: panel revised according to expert review and further curation.

2 Nov 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

2 Nov 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

19 Oct 2016, Gel status: 4

Gene classified by Genomics England curator

Ellen McDonagh (Genomics England Curator)

This gene has been classified as Green List (High Evidence).

19 Oct 2016, Gel status: 2

Added New Source

Ellen McDonagh (Genomics England Curator)

MAPT was added to Parkinson Disease and Complex Parkinsonismpanel. Source: Eligibility statement prior genetic testing

19 Oct 2016, Gel status: 0

Created

Ellen McDonagh (Genomics England Curator)

MAPT was created by ellenmcdonagh

19 Oct 2016, Gel status: 2

Added New Source

Ellen McDonagh (Genomics England Curator)

MAPT was added to Parkinson Disease and Complex Parkinsonismpanel. Sources: Radboud University Medical Center, Nijmegen,Expert,UKGTN